|
 |
|
|
|
|
|
WHAT THEY ARE SAYING

"We had a historic year – our best earnings ever, more than doubling the prior year." |
John Freeland, President and CEO, IRI
Hear More |
|
|
All Products Detail
|
BehaviorScan Rx ad testing is the industry-recognized gold standard testing service. It delivers different TV advertisements in the same market and can link TV viewing to consumer and doctor prescription drug activity. This in-market, split cable design solution provides the most accurate measurement of the impact of DTC advertising on prescription activity. The BehaviorScan Rx ad testing package includes exclusive testing rights in a specified market, consultation on test market selection and test design, execution of test and control advertising plans via cable TV cut-ins, and analysis of results.
|
See
|
|
The impact of your advertising and gain insights from resulting prescription activity
|
Act
|
|
Evaluate and refine your advertising based on test results across markets
|
Win
|
Ensure a return on your advertising campaign investment
|
| TAKE THE NEXT STEP |
|
|
Have a question or need more information about this product? Fill out the form below and an IRI representative will contact you as soon as possible.
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|